P&G filed the lawsuit in 2004 against Teva Pharmaceuticals USA. Teva wanted to market a generic version of Actonel in the United States and had claimed P&G's patent for the drug was not valid. P&G says the court ruling rejected that challenge.
Shares of Procter & Gamble fell 24 cents to close at $66.97, whiles shares of Teva fell 18 cents to close at $49.40.
For up-to-the-minute news, features and links click on http://www.FinancialWire.net
FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation from any company for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on http://www.investrend.com/contact.asp
For a free annual report on a company mentioned in the news, please click on http://investrend.ar.wilink.com/?level=279
To become an investor monitor of independent research for a company in which you are invested, go to the not-for-profit Shareholders Research Alliance, Inc. website by clicking on http://www.shareholdersresearch.com/
The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268
http://www.financialwire.net
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
